Submission Details
| 510(k) Number | K050374 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | February 14, 2005 |
| Decision Date | June 15, 2005 |
| Days to Decision | 121 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
K050374 is an FDA 510(k) clearance for the ADVIA IMS LITHIUM ASSAY, a Assay, Porphyrin, Spectrophotometry, Lithium (Class II — Special Controls, product code NDW), submitted by Bayer Healthcare, LLC (New York, US). The FDA issued a Cleared decision on June 15, 2005, 121 days after receiving the submission on February 14, 2005. This device falls under the Chemistry review panel. Regulated under 21 CFR 862.3560.
| 510(k) Number | K050374 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | February 14, 2005 |
| Decision Date | June 15, 2005 |
| Days to Decision | 121 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
| Product Code | NDW — Assay, Porphyrin, Spectrophotometry, Lithium |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 862.3560 |